Retatrutide reaches its maximum dose faster (12 weeks vs 16-20 weeks) and produces greater weight loss despite a lower milligram dose than tirzepatide
Clinical considerations : -Noncirrhotic MASH: There may be risks to the mother and fetus related to MASH with advanced liver fibrosis (e.g., increased risks of gestational diabetes, hypertensive complications, preterm birth, postpartum hemorrhage)
One concern exists
Seek prompt or urgent referral to a dermatologist if there are red-flag features, including: suspected scarring alopecia (indicated by pain, erythema, scaling, or pustules on the scalp)
This may be more likely when you are early in treatment, recently changed your dose, have not eaten much, or are already dealing with stomach-related side effects
Antioxidant Network